>300,000
tobacco-related deaths each year
145mill
people— 22% of adults —smoke
289,000
estimated TB cases in 2018
Members of The Union Latin America Region
The Union is divided into seven regions to provide a platform for addressing lung health and related issues from a regional perspective. This structure offers members opportunities to network with colleagues who face the same regional challenges and contributes to The Union's deep understanding of local issues.
The Union Latin America Region is made up of organisational and individual members.
The 19th Conference of The Union Latin America Region, took place during the Congress of the Asociación Latinoamericana de Tórax, in Panama, bringing together clinicians, researchers, health care professionals, politicians, the media and people affected by tuberculosis (TB).
Organised by Union members, the conference brings together experts to discuss regional approaches to lung health challenges, including TB, lung disease, tobacco control and air pollution.
UNION NEWS FROM THE Latin america REGION
Conflation of prediction and causality in the TB literature
A forthcoming IJTLD OPEN article addresses the frequent conflation of prediction and causal inference in observational TB studies, and outlines practical recommendations to enhance research precision and transparency.
The rationale for cancer to be made a notifiable disease in India
In this Short Communication (to be published in the Q2 issue of PHA), the authors explain why the Ministry of Health in India should make cancer a notifiable disease.
TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe
Ahead of World TB Day, we present an article that assesses the burden of multimorbidity and the effectiveness of referral pathways at the start of TB treatment across Kenya, Uganda, Zambia and Zimbabwe
Evaluating disability, comorbidities and risk factors after TB treatment: an 18–24 month follow-up in China
Ahead of World TB Day, we present an article that assesses disability, comorbidities and risk factors after TB treatment in China.